GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

前日（2月7日）， 全球骨科手术机器人龙头企业Globus Medical（NYSE: GMED）宣布以每股5.85美元的价格收购慢性疼痛治疗公司Nevro（NYSE: NVRO）全部股份，总股权价值达2.5亿美元（约合18.2亿元人民币） 。这一价格较Nevro过去90天的平均股价溢价27%，较30天平均股价溢价38%，交易预计于2025年第二季度末完成。

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

宾夕法尼亚州AUDUBON - 市值118.1亿美元、在InvestingPro获得"优秀"财务健康评级的肌肉骨骼解决方案公司Globus Medical, Inc. (NYSE: GMED)已同意以约2.5亿美元现金收购专注于慢性疼痛治疗的全球医疗设备公司Nevro Corp. (NYSE: NVRO)。根据今日宣布的收购协议，Globus ...

Globus Medical (GMED) and Nevro Corp. (NVRO) have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an ...

Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

周五，Piper Sandler分析师Adam Maeder将市值2.14亿美元的医疗设备公司Nevro Corp (NYSE: NVRO )的股票评级从减持上调至中性，并将目标价从6.00美元下调至5.85美元。此次调整是在Nevro宣布与Globus Medical Inc. (NYSE: GMED )达成最终收购协议后做出的，后者将以每股5.85美元的现金价格收购Nevro。

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...